VTAK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Catheter Precision Inc (VTAK) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available. The technical indicators are bearish, there are no positive trading signals, and the financial performance shows significant losses despite revenue growth. The lack of positive news or catalysts further supports a hold recommendation.
The MACD is negative and expanding downward, RSI is neutral at 21.014, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 1.118), with a pre-market price of 1.1, indicating further downside risk.
Revenue increased by 135.42% YoY in Q3 2025, and gross margin improved slightly to 92.04%.
Net income dropped significantly by -45.36% YoY, EPS declined by -95.55% YoY, and the stock has a high probability of further short-term declines (-2.51% in the next week, -2.34% in the next month). No recent news, insider activity, or hedge fund interest.
In Q3 2025, revenue increased to $226,000 (up 135.42% YoY), but net income dropped to -$2,251,000 (down -45.36% YoY). EPS fell to -1.7 (down -95.55% YoY), indicating worsening profitability.
No analyst ratings or price target changes available.
